KIMBERLY LEE: Open Payments
NPI 1205457595 · LIMA, OH. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,083 in 59 payments from 12 companies in 2025. Trend: 2023 $1,376 · 2024 $1,208 · 2025 $1,083
Food & beverage: $1,083
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 20 | $282 |
| AstraZeneca Pharmaceuticals LP | 7 | $151 |
| Otsuka America Pharmaceutical, Inc. | 8 | $138 |
| Novo Nordisk Inc | 6 | $101 |
| Lilly USA, LLC | 5 | $96 |
| Axsome Therapeutics, Inc. | 1 | $78 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 4 | $74 |
| Boston Scientific Corporation | 2 | $62 |
| Exact Sciences Corporation | 2 | $38 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $29 |
Products named: VRAYLAR, REXULTI, MOUNJARO, AIRSUPRA, Auvelity, CAPLYTA, WATCHMAN Access System, FARXIGA.
Industry payments across OH — which companies pay providers there.
